[Form 4] DocuSign, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Robert Chatwani, President General Manager, Growth at DocuSign, Inc. (DOCU), reported a sale of company stock on 09/11/2025. The Form 4 shows a disposition of 983 shares at a price of $79.39 per share, leaving 71,143 shares beneficially owned in a direct form. The filing indicates the transaction was executed pursuant to a Rule 10b5-1 trading plan, and the form was signed by an attorney-in-fact.

Positive

• Transaction disclosed promptly on Form 4 with full details (date, price, shares, post-transaction ownership)
• Sale executed under a Rule 10b5-1 plan, indicating a pre-established trading arrangement that supports compliance with insider trading rules

Negative

• Direct holdings reduced by 983 shares, from prior level to 71,143 shares following the sale

Insights

Financial Analyst

TL;DR: A routine insider sale under a 10b5-1 plan; modest reduction in direct holdings, no new material corporate information.

The reported sale of 983 shares at $79.39 is explicitly documented and executed under a pre-established Rule 10b5-1 plan, which typically signals a scheduled disposition rather than opportunistic trading. The remaining direct holding of 71,143 shares is shown, providing clear ownership context. This disclosure improves transparency but does not, on its face, change the companys financial position or operations.

Corporate Governance Expert

TL;DR: Proper insider disclosure and use of a 10b5-1 plan reduce governance concerns about timing of the sale.

The Form 4 includes the required information: reporting person identity, relationship to issuer, transaction details, price, and post-transaction ownership. The checked box and explanatory note confirm reliance on a Rule 10b5-1 plan, which generally provides an affirmative defense to claims of trading on material nonpublic information when properly established. The filing is procedurally complete and signed by an authorized attorney-in-fact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chatwani Robert

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President General Mgr, Growth

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		S		983(1)	D	$79.39	71,143	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DOCU insider Robert Chatwani report on 09/11/2025?

The Form 4 reports a sale of 983 shares of DocuSign common stock at $79.39 per share on 09/11/2025.

How many DocuSign shares does Robert Chatwani own after this transaction?

The filing shows 71,143 shares beneficially owned following the reported sale.

Was the sale executed under a Rule 10b5-1 trading plan?

Yes. The Form 4 indicates the transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person.

What price was the DOCU stock sold for in this transaction?

The reported sale price was $79.39 per share.

Who signed the Form 4 for Robert Chatwani?

The Form 4 was signed by /s/ Derrick Chapman, Attorney-in-fact on 09/11/2025.